305 related articles for article (PubMed ID: 28149880)
1. Aldehyde dehydrogenases in cancer stem cells: potential as therapeutic targets.
Clark DW; Palle K
Ann Transl Med; 2016 Dec; 4(24):518. PubMed ID: 28149880
[TBL] [Abstract][Full Text] [Related]
2. Targeting aldehyde dehydrogenase for prostate cancer therapies.
Ma M; He W; Zhao K; Xue L; Xia S; Zhang B
Front Oncol; 2022; 12():1006340. PubMed ID: 36300093
[TBL] [Abstract][Full Text] [Related]
3. Targeting Aldehyde Dehydrogenases to Eliminate Cancer Stem Cells in Gynecologic Malignancies.
Muralikrishnan V; Hurley TD; Nephew KP
Cancers (Basel); 2020 Apr; 12(4):. PubMed ID: 32295073
[TBL] [Abstract][Full Text] [Related]
4. The role of aldehyde dehydrogenase (ALDH) in cancer drug resistance.
Januchowski R; Wojtowicz K; Zabel M
Biomed Pharmacother; 2013 Sep; 67(7):669-80. PubMed ID: 23721823
[TBL] [Abstract][Full Text] [Related]
5. High NRF2 level mediates cancer stem cell-like properties of aldehyde dehydrogenase (ALDH)-high ovarian cancer cells: inhibitory role of all-trans retinoic acid in ALDH/NRF2 signaling.
Kim D; Choi BH; Ryoo IG; Kwak MK
Cell Death Dis; 2018 Aug; 9(9):896. PubMed ID: 30166520
[TBL] [Abstract][Full Text] [Related]
6. The Multifaceted Role of Aldehyde Dehydrogenases in Prostate Cancer Stem Cells.
Püschel J; Dubrovska A; Gorodetska I
Cancers (Basel); 2021 Sep; 13(18):. PubMed ID: 34572930
[TBL] [Abstract][Full Text] [Related]
7. Aldehyde dehydrogenases and cancer stem cells.
Xu X; Chai S; Wang P; Zhang C; Yang Y; Yang Y; Wang K
Cancer Lett; 2015 Dec; 369(1):50-7. PubMed ID: 26319899
[TBL] [Abstract][Full Text] [Related]
8. ALDH as a Stem Cell Marker in Solid Tumors.
Toledo-Guzmán ME; Hernández MI; Gómez-Gallegos ÁA; Ortiz-Sánchez E
Curr Stem Cell Res Ther; 2019; 14(5):375-388. PubMed ID: 30095061
[TBL] [Abstract][Full Text] [Related]
9. The Concept of Cancer Stem Cells: Elaborating on ALDH1B1 as an Emerging Marker of Cancer Progression.
Tsochantaridis I; Roupas A; Mohlin S; Pappa A; Voulgaridou GP
Life (Basel); 2023 Jan; 13(1):. PubMed ID: 36676146
[TBL] [Abstract][Full Text] [Related]
10. Inhibitors of aldehyde dehydrogenases of the 1A subfamily as putative anticancer agents: Kinetic characterization and effect on human cancer cells.
Jiménez R; Pequerul R; Amor A; Lorenzo J; Metwally K; Avilés FX; Parés X; Farrés J
Chem Biol Interact; 2019 Jun; 306():123-130. PubMed ID: 30958995
[TBL] [Abstract][Full Text] [Related]
11. Identification of cancer-type specific expression patterns for active aldehyde dehydrogenase (ALDH) isoforms in ALDEFLUOR assay.
Zhou L; Sheng D; Wang D; Ma W; Deng Q; Deng L; Liu S
Cell Biol Toxicol; 2019 Apr; 35(2):161-177. PubMed ID: 30220009
[TBL] [Abstract][Full Text] [Related]
12. Targeting cancer stem cells by using the nanoparticles.
Hong IS; Jang GB; Lee HY; Nam JS
Int J Nanomedicine; 2015; 10(Spec Iss):251-60. PubMed ID: 26425092
[TBL] [Abstract][Full Text] [Related]
13. Use of retinoic acid/aldehyde dehydrogenase pathway as potential targeted therapy against cancer stem cells.
Moreb JS; Ucar-Bilyeu DA; Khan A
Cancer Chemother Pharmacol; 2017 Feb; 79(2):295-301. PubMed ID: 27942929
[TBL] [Abstract][Full Text] [Related]
14. Emerging Roles of Aldehyde Dehydrogenase Isoforms in Anti-cancer Therapy Resistance.
Zanoni M; Bravaccini S; Fabbri F; Arienti C
Front Med (Lausanne); 2022; 9():795762. PubMed ID: 35299840
[TBL] [Abstract][Full Text] [Related]
15. Aldehyde dehydrogenases and their role in carcinogenesis.
Lindahl R
Crit Rev Biochem Mol Biol; 1992; 27(4-5):283-335. PubMed ID: 1521460
[TBL] [Abstract][Full Text] [Related]
16. Aldehyde dehydrogenase in solid tumors and other diseases: Potential biomarkers and therapeutic targets.
Xia J; Li S; Liu S; Zhang L
MedComm (2020); 2023 Feb; 4(1):e195. PubMed ID: 36694633
[TBL] [Abstract][Full Text] [Related]
17. CD10
Ffrench B; Gasch C; Hokamp K; Spillane C; Blackshields G; Mahgoub TM; Bates M; Kehoe L; Mooney A; Doyle R; Doyle B; O'Donnell D; Gleeson N; Hennessy BT; Stordal B; O'Riain C; Lambkin H; O'Toole S; O'Leary JJ; Gallagher MF
Cell Death Dis; 2017 Oct; 8(10):e3128. PubMed ID: 29048400
[TBL] [Abstract][Full Text] [Related]
18. The SOX9-Aldehyde Dehydrogenase Axis Determines Resistance to Chemotherapy in Non-Small-Cell Lung Cancer.
Voronkova MA; Rojanasakul LW; Kiratipaiboon C; Rojanasakul Y
Mol Cell Biol; 2020 Jan; 40(2):. PubMed ID: 31658996
[TBL] [Abstract][Full Text] [Related]
19. Characterization of aldehyde dehydrogenase 1 high ovarian cancer cells: Towards targeted stem cell therapy.
Sharrow AC; Perkins B; Collector MI; Yu W; Simons BW; Jones RJ
Gynecol Oncol; 2016 Aug; 142(2):341-8. PubMed ID: 27017984
[TBL] [Abstract][Full Text] [Related]
20. Lung cancer stem cells-origin, characteristics and therapy.
Prabavathy D; Swarnalatha Y; Ramadoss N
Stem Cell Investig; 2018; 5():6. PubMed ID: 29682513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
